拓新药业：2025年度业绩预告

Core Viewpoint - The company, Tuoxin Pharmaceutical, anticipates a significant increase in net profit loss for the fiscal year 2025, projecting a loss between 54 million to 73 million yuan, compared to a loss of approximately 19.88 million yuan in the previous year, indicating a decline of 171.56% to 267.11% year-over-year [1] Financial Performance - The projected net profit loss for 2025 is estimated to be between 54 million to 73 million yuan [1] - The previous year's loss was reported at 19.88 million yuan [1] - The anticipated decline in net profit loss represents an increase in losses by 171.56% to 267.11% compared to the previous year [1]